Lenvatinib tablet & Pomalidomide price | Forum

Topic location: Forum home » General » General Chat
Medixo Centre
Medixo Centre Mar 27
Lenvatinib is a multi-target drug that is different from other tyrosine kinase inhibitors (TKIs). It is currently approved for liver cancer, thyroid cancer and renal cancer. It is a new targeted drug for the treatment of liver cancer. You can check lenvatinib price.

Pomalidomide is a third-generation immunomodulator (IMiD). In 2013, the USFDA approved pomalidomide for the treatment of relapsed and refractory MM. You can check Pomalidomide price in USA by contacting us.